WST logo

WST Stock Overview

Profile

Full Name:

West Pharmaceutical Services, Inc.

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

United States

IPO:

March 17, 1980

Indexes:

S&P 500

Website:

http://www.westpharma.com

Description:

West Pharmaceutical Services, Inc. produces and sells injection pharmaceutical packaging and delivery systems for medicines and medical devices. The company was founded in 1923 and is headquartered in Exton, Pennsylvania. The company operates in two segments: The proprietary products segment offers patented packaging, sealing, and delivery of medicines, as well as analytical laboratory services and comprehensive solutions, primarily for customers of biological, generic, and pharmaceutical products. The contract manufacturing segment is involved in the design, production, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injection, and other drug delivery systems, as well as consumer goods. This segment serves pharmaceutical, diagnostic, and medical companies.

Key Details

Price

$231.47

Market Cap

$16.74 B(Large cap)

Last Dividend

$0.21

TTM Dividend Yield

0.35%

Annual Revenue

$2.89 B(-1.92% YoY)

Annual EPS

$6.69(-15.10% YoY)

PE Ratio

34.60

Annual ROE

17.71%

Annual Debt To Equity

0.00

Beta

0.34

Events Calendar

Earnings

Next earnings date:

Apr 25, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

Apr 30, 2025

Recent ex-dividend date:

Feb 7, 2025
Splits

Next split:

N/A

Recent split:

Sep 27, 2013

Analyst ratings

Recent major analysts updates

Feb 14, 25 Keybanc
Overweight
Jan 8, 25 Citigroup
Buy
Dec 13, 24 Wolfe Research
Peer Perform
Dec 13, 24 B of A Securities
Buy
Dec 12, 24 UBS
Buy
Feb 16, 24 UBS
Neutral
Feb 13, 24 Keybanc
Overweight
Feb 7, 24 Jefferies
Buy
Oct 27, 23 Stephens & Co.
Overweight
Aug 30, 23 Keybanc
Overweight

Screeners with WST included

US stocks
High Piotroski score stocks
S&P 500 companies earnings calendar
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 5 years
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar
Healthcare sector

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$231.47
WST price is $231.47

Price All-time High

$471.34
WST price is currently -50.89% below its historical high of $471.34

Price Analysts Target

$285.00
WST price is currently -18.78% lower than the consensus analysts' forecast

Price Most Recent Change

-0.64%
WST price was down -0.64% on Mar 7, 2025

Price YTD Change

-29.17%
WST price is down -29.17% since January 1st

Price 3-Year Change

-37.92%
WST price is down -37.92% over the past 3 years

Market cap

Market Cap

$16.74 B
WST market capitalization is $16.74 billion

Market Cap 3-Year Change

-39.63%
WST market capitalization is down -39.63% over the past 3 years

Market Cap All-time High

$34.92 B
WST market capitalization is currently -52.07% below its historical high of $34.92 billion

Market Cap Sector Rank

94.9%
WST market capitalization is higher than 94.9% of companies in Healthcare sector

Technical

Beta

0.34
WST beta is 0.34

200-day SMA

$309.13
WST price is currently -25.12% below its 200-day simple moving average

14-day RSI

36.55
WST 14-day relative strength index is 36.55

30-day Relative Volume

0.73
WST 30-day relative volume is 0.73

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.21
WST last dividend was $0.21 per share, with an ex-dividend date of February 7, 2025

Next Dividend

$0.21
WST has announced a dividend of $0.21 per share, with an ex-dividend date set for April 30, 2025

Dividend per share

Annual Dividend Per Share

$0.81
WST annual dividend per share is $0.81

Annual Dividend Per Share Sector Rank

35.29%
WST annual dividend per share is higher than 35.29% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+5.19%
WST annual dividend per share is up +5.19% year-on-year

Annual Dividend Per Share 3-Year Change

+17.39%
WST annual dividend per share is up +17.39% over the past 3 years

Dividend yield

Annual Dividend Yield

0.35%
WST annual dividend yield is 0.35%

Annual Dividend Yield Sector Rank

9.52%
WST annual dividend yield is higher than 9.52% of companies in Healthcare sector

Other

Annual Payout Ratio

12.00%
WST annual payout ratio is 12.00%

Annual Dividends Paid

$59.10 M
WST annual dividends paid is $59.10 million

Annual FCF

$276.40 M
WST annual free cash flow is $276.40 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$2.89 B
WST annual revenue is $2.89 billion

Annual Revenue Analysts Estimate

$2.89 B
WST annual revenue is currently +0.06% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-1.92%
WST annual revenue is down -1.92% year-on-year

Annual Revenue Sector Rank

88.11%
WST annual revenue is higher than 88.11% of companies in Healthcare sector

Profit

Annual Gross Profit

$998.50 M
WST annual gross profit is $998.50 million

Annual Gross Margin

34.51%
WST annual gross profit margin is 34.51%

Annual Operating Profit

$569.90 M
WST annual operating income is $569.90 million

Annual Operating Margin

19.70%
WST annual operating profit margin is 19.70%

Annual Net Income

$492.70 M
WST annual net profit is $492.70 million

Annual Net Margin

17.03%
WST annual net profit margin is 17.03%

EPS

Annual EPS

$6.69
WST annual earnings per share is $6.69

Annual EPS Analysts Estimate

$6.10
WST annual earnings per share is currently +9.72% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-15.1%
WST annual earnings per share is down -15.1% year-on-year

Annual EPS Sector Rank

96.88%
WST annual earnings per share is higher than 96.88% of companies in Healthcare sector

ROA & ROE

Annual ROA

13.19%
WST annual return on assets is 13.19%

Annual ROE

17.71%
WST annual return on equity is 17.71%

EBIT & EBITDA

Annual EBIT

$569.90 M
WST annual earnings before interest & taxes is $569.90 million

Annual EBITDA

$725.30 M
WST annual EBITDA is $725.30 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

34.60
WST price to earnings ratio is 34.60

PE Ratio Sector Rank

65.02%
WST price to earnings ratio is higher than 65.02% of companies in Healthcare sector

PB Ratio

PB Ratio

6.24
WST price to book ratio is 6.24

PB Ratio Sector Rank

86.24%
WST price to book ratio is higher than 86.24% of companies in Healthcare sector

PS Ratio

PS Ratio

5.78
WST price to sales ratio is 5.78

PS Ratio Sector Rank

67.14%
WST price to sales ratio is higher than 67.14% of companies in Healthcare sector

Enterprise value

Enterprise Value

$16.55 B
WST enterprise value is $16.55 billion

Enterprise Value Sector Rank

94.19%
WST enterprise value is higher than 94.19% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

22.39
WST EV/EBITDA is 22.39

EV/EBITDA Sector Rank

92.12%
WST EV/EBITDA is higher than 92.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

5.91
WST annual current ratio is 5.91

Annual Quick Ratio

4.33
WST annual quick ratio is 4.33

Leverage

Annual Debt To Equity

0.00
WST annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

189.97
WST annual interest coverage ratio is 189.97

Risk & Stability

Piotroski F-Score

6
WST piotroski f-score is 6

Altman Z-Score

13.67
WST altman z-score is 13.67

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$3.64 B
WST annual total assets is $3.64 billion

Annual Non Current Assets

$2.11 B
WST annual long term assets is $2.11 billion

Annual Current Assets

$1.41 B
WST annual total current assets is $1.41 billion

Annual Cash & Cash Equivalents

$484.60 M
WST annual cash & cash equivalents is $484.60 million

Equity

Annual Book Value

$2.68 B
WST annual book value is $2.68 billion

Annual Working Capital

$1.17 B
WST annual working capital is $1.17 billion

Liabilities

Annual Total Liabilities

$961.10 M
WST annual total liabilities is $961.10 million

Annual Total Long Term Liabilities

$410.70 M
WST annual total long term liabilities is $410.70 million

Annual Current Liabilities

$239.30 M
WST annual total current liabilities is $239.30 million

Annual Accounts Payable

$239.30 M
WST annual accounts payable is $239.30 million

Debt

Annual Total Debt

$302.30 M
WST annual total debt is $302.30 million

Annual Total Debt 1-Year Change

-2.17%
WST annual total debt is down -2.17% year-on-year

Annual Long Term Debt

$284.40 M
WST annual long term debt is $284.40 million

Annual Short Term Debt

$17.90 M
WST annual short term debt is $17.90 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$2.32 B
WST annual total expenses is $2.32 billion

Annual Operating Expenses

$428.60 M
WST annual total operating expenses is $428.60 million

Annual Cost Of Goods Sold

$1.89 B
WST annual cost of goods sold is $1.89 billion

Annual SGA

$338.50 M
WST annual SGA is $338.50 million

Annual D&A

$155.40 M
WST annual depreciation & amortization is $155.40 million

Annual Interest Expense

$3.00 M
WST annual interest expense is $3.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$653.40 M
WST annual cash flow from operations is $653.40 million

Annual CFO 1-Year Change

-15.85%
WST annual cash flow from operations is down -15.85% year-on-year

Annual CFI

-$378.70 M
WST annual cash flow from investing activities is -$378.70 million

Annual CFI 1-Year Change

-2.71%
WST annual cash flow from investing activities is down -2.71% year-on-year

Annual CFF

-$622.60 M
WST annual cash flow from financing activities is -$622.60 million

Annual CFF 1-Year Change

-35.47%
WST annual cash flow from financing activities is down -35.47% year-on-year

Free CashFlow

Annual FCF

$276.40 M
WST annual free cash flow is $276.40 million

Annual FCF 1-Year Change

-33.32%
WST annual free cash flow is down -33.32% year-on-year

CAPEX

Annual CAPEX

$377.00 M
WST annual capital expenditures is $377.00 million

Annual CAPEX 1-Year Change

+4.14%
WST annual capital expenditures is up +4.14% year-on-year

Institutional Ownership

Similar stocks

COO logo
Cooper Companies (COO)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
MOH logo
Molina Healthcare (MOH)
GMAB logo
Genmab A/S (GMAB)
ICLR logo
ICON Public Limited (ICLR)
PODD logo
Insulet (PODD)
BAX logo
Baxter International (BAX)
RPRX logo
Royalty Pharma (RPRX)
HOLX logo
Hologic (HOLX)

FAQ

  • What is the ticker symbol for West Pharmaceutical Services?
  • Does West Pharmaceutical Services pay dividends?
  • What sector is West Pharmaceutical Services in?
  • What industry is West Pharmaceutical Services in?
  • What country is West Pharmaceutical Services based in?
  • When did West Pharmaceutical Services go public?
  • Is West Pharmaceutical Services in the S&P 500?
  • Is West Pharmaceutical Services in the NASDAQ 100?
  • Is West Pharmaceutical Services in the Dow Jones?
  • When was West Pharmaceutical Services's last earnings report?
  • When does West Pharmaceutical Services report earnings?
  • Should I buy West Pharmaceutical Services stock now?

What is the ticker symbol for West Pharmaceutical Services?

The ticker symbol for West Pharmaceutical Services is NYSE:WST

Does West Pharmaceutical Services pay dividends?

Yes, West Pharmaceutical Services pays dividends. The last payment was $0.21, with an ex-dividend date on February 7, 2025

What sector is West Pharmaceutical Services in?

West Pharmaceutical Services is in the Healthcare sector

What industry is West Pharmaceutical Services in?

West Pharmaceutical Services is in the Medical Instruments & Supplies industry

What country is West Pharmaceutical Services based in?

West Pharmaceutical Services is headquartered in United States

When did West Pharmaceutical Services go public?

West Pharmaceutical Services's initial public offering (IPO) was on March 17, 1980

Is West Pharmaceutical Services in the S&P 500?

Yes, West Pharmaceutical Services is included in the S&P 500 index

Is West Pharmaceutical Services in the NASDAQ 100?

No, West Pharmaceutical Services is not included in the NASDAQ 100 index

Is West Pharmaceutical Services in the Dow Jones?

No, West Pharmaceutical Services is not included in the Dow Jones index

When was West Pharmaceutical Services's last earnings report?

West Pharmaceutical Services's most recent earnings report was on Feb 13, 2025

When does West Pharmaceutical Services report earnings?

The next expected earnings date for West Pharmaceutical Services is Apr 25, 2025

Should I buy West Pharmaceutical Services stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions